These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7673402)

  • 1. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan.
    Takeshita A; Nagayama Y; Yokoyama N; Ishikawa N; Ito K; Yamashita T; Obara T; Murakami Y; Kuma K; Takamatsu J
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2607-11. PubMed ID: 7673402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two novel mutations in the sixth transmembrane segment of the thyrotropin receptor gene causing hyperfunctioning thyroid nodules.
    Gozu H; Avsar M; Bircan R; Claus M; Sahin S; Sezgin O; Deyneli O; Paschke R; Cirakoglu B; Akalin S
    Thyroid; 2005 Apr; 15(4):389-97. PubMed ID: 15876166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
    Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
    J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low incidence of the stimulatory G protein alpha-subunit mutations in autonomously functioning thyroid adenomas in Japan.
    Tanaka K; Nagayama Y; Takeshita A; Namba H; Yamashita S; Niwa M; Nagataki S
    Thyroid; 1996 Jun; 6(3):195-9. PubMed ID: 8837326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in the Japanese population.
    Vanvooren V; Uchino S; Duprez L; Costa MJ; Vandekerckhove J; Parma J; Vassart G; Dumont JE; Van Sande J; Noguchi S
    Eur J Endocrinol; 2002 Sep; 147(3):287-91. PubMed ID: 12213664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas.
    Russo D; Arturi F; Suarez HG; Schlumberger M; Du Villard JA; Crocetti U; Filetti S
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1548-51. PubMed ID: 8636365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Point mutations of the thyrotropin receptor gene in autonomously functioning thyroid gland nodules: correlation with clinical findings and morphology].
    Lax SF; Semlitsch G; Schauer S; Zatloukal K; Langsteger W; Eber O; Höfler G
    Verh Dtsch Ges Pathol; 1997; 81():145-50. PubMed ID: 9474865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel activating mutation in the thyrotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient.
    Kosugi S; Hai N; Okamoto H; Sugawa H; Mori T
    Eur J Endocrinol; 2000 Oct; 143(4):471-7. PubMed ID: 11022192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules.
    Führer D; Holzapfel HP; Wonerow P; Scherbaum WA; Paschke R
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3885-91. PubMed ID: 9360556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor].
    Kosugi S
    Nihon Rinsho; 2002 Feb; 60(2):291-6. PubMed ID: 11857916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in thyroid hyperfunctioning adenomas.
    Russo D; Arturi F; Wicker R; Chazenbalk GD; Schlumberger M; DuVillard JA; Caillou B; Monier R; Rapoport B; Filetti S
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1347-51. PubMed ID: 7714109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms.
    Tonacchera M; Vitti P; Agretti P; Ceccarini G; Perri A; Cavaliere R; Mazzi B; Naccarato AG; Viacava P; Miccoli P; Pinchera A; Chiovato L
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4155-8. PubMed ID: 10566665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the thyrotropin receptor signal transduction pathway in the hyperfunctioning thyroid nodules from multinodular goiters: a study in the Turkish population.
    Gozu H; Avsar M; Bircan R; Sahin S; Deyneli O; Cirakoglu B; Akalin S
    Endocr J; 2005 Oct; 52(5):577-85. PubMed ID: 16284436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil.
    Nogueira CR; Kopp P; Arseven OK; Santos CL; Jameson JL; Medeiros-Neto G
    Thyroid; 1999 Nov; 9(11):1063-8. PubMed ID: 10595453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein and thyrotropin receptor mutations in thyroid neoplasia.
    Esapa C; Foster S; Johnson S; Jameson JL; Kendall-Taylor P; Harris PE
    J Clin Endocrinol Metab; 1997 Feb; 82(2):493-6. PubMed ID: 9024242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters.
    Holzapfel HP; Führer D; Wonerow P; Weinland G; Scherbaum WA; Paschke R
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4229-33. PubMed ID: 9398745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of TSH receptor and Gsalpha mutations in 45 autonomously functioning thyroid nodules in Japan.
    Nishihara E; Amino N; Maekawa K; Yoshida H; Ito M; Kubota S; Fukata S; Miyauchi A
    Endocr J; 2009; 56(6):791-8. PubMed ID: 19550078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two rare TSH receptor amino acid substitutions in toxic thyroid adenomas.
    Nanba K; Usui T; Minamiguchi S; Mori Y; Watanabe Y; Honda K; Asato R; Nakao K; Kawashima ST; Yuno A; Tamanaha T; Tagami T; Naruse M; Akiyama Y; Shimatsu A
    Endocr J; 2012; 59(1):13-9. PubMed ID: 22001338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades.
    Parma J; Van Sande J; Swillens S; Tonacchera M; Dumont J; Vassart G
    Mol Endocrinol; 1995 Jun; 9(6):725-33. PubMed ID: 8592518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations.
    Lueblinghoff J; Eszlinger M; Jaeschke H; Mueller S; Bircan R; Gozu H; Sancak S; Akalin S; Paschke R
    Thyroid; 2011 Mar; 21(3):221-9. PubMed ID: 21190443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.